David Hudesman, MD, and José Scher, MD, on COVID-19 in Patients With Immune-Mediated Diseases

In this podcast, gastroenterologist David Hudesman, MD, and rheumatologist José Scher, MD, discuss their prospective case series involving patients with known immune-mediated inflammatory diseases who were receiving anticytokine biologics, other immunomodulatory therapies, or both when confirmed or highly suspected symptomatic COVID-19 developed.

Additional Resource:

Haberman R, Axelrad J, Chen A, et al. Covid-19 in immune-mediated inflammatory diseases - case series from New York. Published online April 29, 2020. N Engl J Med. doi:10.1056/NEJMc2009567

David Hudesman, MD, is codirector of the Inflammatory Bowel Disease Center at NYU Langone Health and is an associate professor of medicine at the NYU School of Medicine in New York City.

José U. Scher, MD, is director of the Psoriatic Arthritis Center and the Arthritis Clinic at NYU Langone Orthopedic Hospital Health and is an associate professor of medicine at the NYU School of Medicine in New York City.